To assess the efficacy of FGF-21, Metrnl, and sortilin as biomarkers for differentiating individuals with metabolic syndrome, insulin resistance, carbohydrate disorders, and dyslipidemia, receiver operating characteristic (ROC) curve analysis was performed. The gene discussed is FGF21; the disease is Insulin resistance.